almagate has been researched along with Pigmentary Retinopathy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilar, E; Banin, E; Bird, A; Dorrell, MI; Friedlander, M; Gariano, R; Gasmi, M; Heckenlively, J; Jacobson, R; Ramirez, GA; Siuzdak, G; Yanes, O | 1 |
Iaculli, C; Noci, ND; Prascina, F; Querques, G | 1 |
2 other study(ies) available for almagate and Pigmentary Retinopathy
Article | Year |
---|---|
Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stress.
Topics: Angiogenesis Inhibitors; Animals; Antioxidants; Aptamers, Nucleotide; Disease Models, Animal; Electroretinography; Gene Expression; Gene Expression Profiling; Gene Transfer Techniques; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Growth Factors; Opsins; Oxidative Stress; Receptors, LDL; Retina; Retinal Cone Photoreceptor Cells; Retinal Neovascularization; Retinal Pigment Epithelium; Retinal Rod Photoreceptor Cells; Retinitis Pigmentosa; Rhodopsin; Vascular Endothelial Growth Factor A | 2009 |
Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Adult; Aptamers, Nucleotide; Carbonic Anhydrase Inhibitors; Drug Resistance; Fundus Oculi; Humans; Macular Edema; Male; Retinitis Pigmentosa; Retreatment; Tomography, Optical Coherence; Visual Field Tests; Vitreous Body | 2009 |